The same potency issues apply to both cells, although as I pointed out earlier Rexlemestrocel-L being a more homogeneous cell population is likely to be easier to characterise.
The same potency issues apply to both cells, although as I...
-
- There are more pages in this discussion • 757 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.060(4.60%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $17.98M | 14.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 70899 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 85728 | 17 |
View Market Depth
| Last trade - 14.58pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |